These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing. Gruber SB Gastroenterology; 2006 Feb; 130(2):577-87. PubMed ID: 16472609 [No Abstract] [Full Text] [Related]
8. Correspondence re: G. Anderson et al., Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. Cancer Res., 61: 8274-8283, 2001. Rubin H Cancer Res; 2002 Nov; 62(21):6350-1; author reply 6351. PubMed ID: 12414668 [No Abstract] [Full Text] [Related]
9. [Colorectal cancer: mismatch repair deficiency, genomic instability, tolerance to apoptosis and assessment of risk]. Tronov VA; Kramarenko II; Karpukhin AV Vopr Onkol; 2005; 51(2):159-66. PubMed ID: 16222994 [No Abstract] [Full Text] [Related]
10. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Aaltonen L; Johns L; Järvinen H; Mecklin JP; Houlston R Clin Cancer Res; 2007 Jan; 13(1):356-61. PubMed ID: 17200375 [TBL] [Abstract][Full Text] [Related]
11. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency. Jensen LH; Lindebjerg J; Byriel L; Kolvraa S; Crüger DG Colorectal Dis; 2008 Jun; 10(5):490-7. PubMed ID: 17868408 [TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways. Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962 [TBL] [Abstract][Full Text] [Related]
14. Is it time to abandon microsatellite instability as a pre-screen for selecting families for mutation testing for mismatch repair genes? Evans GD; Lalloo F; Mak T; Speake D; Hill J J Clin Oncol; 2006 Apr; 24(12):1960-2; author reply 1962-3. PubMed ID: 16622277 [No Abstract] [Full Text] [Related]
15. Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: the state of the art. Valentini AM; Armentano R; Pirrelli M; Caruso ML Cancer Treat Rev; 2006 Dec; 32(8):607-18. PubMed ID: 17055172 [TBL] [Abstract][Full Text] [Related]
16. [Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR]. Tronov VA; Kramarenko II; Maĭorova EN; Zakharov SF Genetika; 2007 Apr; 43(4):537-44. PubMed ID: 17555131 [TBL] [Abstract][Full Text] [Related]
17. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome. Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622 [TBL] [Abstract][Full Text] [Related]